| Financial Year |
March 31 2023 |
| Monetary Funds |
1,480,442,605.53 |
| Held-for-trading Financial Assets |
70,000,000.00 |
| Notes Receivable |
67,937,820.60 |
| Accounts Receivable |
757,642,400.80 |
| Advances to Suppliers |
9,607,030.35 |
| Other Receivables |
19,191,901.30 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
324,382,607.80 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
13,025,462.74 |
| Total Current Assets |
2,782,612,225.22 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
194,865,313.10 |
| Fixed Assetes |
184,336,777.33 |
| Under-construction Projects |
133,211,912.78 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
74,765,180.00 |
| R&D expenses |
-- |
| Goodwill |
1,391,483,923.95 |
| Long-Term Deferred and Prepaid Expenses |
162,500.00 |
| Deferred Income Tax Assets |
17,987,910.23 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
2,019,242,280.01 |
| Total Assets |
4,801,854,505.23 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
12,285,900.00 |
| Accounts Payable |
121,557,405.19 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
11,079,230.27 |
| Taxes Payable |
34,695,943.37 |
| Interest Payable |
-- |
| Dividend Payable |
22,437,595.24 |
| Other payables |
30,979,246.62 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
17,468,783.92 |
| Sub-Total of Current Liabilities |
267,008,909.85 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
5,013,719.42 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
5,534,081.27 |
| Total Liabilities |
272,542,991.12 |
| Paid-In Capital(Or Share Stock) |
381,274,377.00 |
| Capital Surplus |
2,326,826,964.89 |
| Surplus Reserve |
160,808,726.97 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,591,529,320.24 |
| Minority Stockholder's Interest |
90,463,362.39 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,438,848,151.72 |
| Owner's Equity（Stockholder's Equity） |
4,529,311,514.11 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,801,854,505.23 |
